AUPH Net Income Growth
Aurinia Pharmaceuticals Inc · Net Income Growth
AUPH Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported418.03%period ending
AUPH TTM Net Income YoY % (-413.60% → 418.03%)
Year-over-year change
High-resolution chart · PNG
AUPH net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 418.0322% | |
| 648.4327% | |
| 4,893.0807% | |
| 445.1446% | |
| 220.4314% | |
| 163.6878% | |
| 107.3725% | |
| 70.7842% | |
| 30.7756% | |
| 35.3394% | |
| 27.8795% | |
| 33.1425% | |
| 53.5911% | |
| 42.4814% | |
| 40.2208% | |
| 25.8557% | |
| -6.1853% | |
| -32.322% | |
| -76.2427% | |
| 8.9826% | |
| 0.2703% | |
| 7.443% | |
| 17.0906% | |
| -176.1278% | |
| -141.566% | |
| -124.9058% | |
| -93.1472% | |
| -17.2156% | |
| -28.6059% | |
| -77.8962% | |
| 9.4248% | |
| 30.2587% | |
| 32.0365% | |
| 51.6282% | |
| -203.8935% | |
| -301.0424% | |
| -321.3526% | |
| -403.612% | |
| -26.4246% | |
| 2.6226% | |
| 0.8228% | |
| 29.7402% | |
| -10.6866% | |
| -90.7867% | |
| -71.0718% | |
| -195.9964% | |
| -604.0401% | |
| -11.9564% | |
| -13.1729% | |
| 32.0937% | |
| 75.5082% | |
| 16.019% | |
| -25.0204% | |
| -4,083.3039% | |
| -325.0981% | |
| -775.4459% | |
| -236.2319% | |
| 103.3859% | |
| 37.6265% | |
| 157.3875% | |
| 30.6986% | |
| -153.425% | |
| 47.7627% | |
| 63.0788% | |
| 68.3165% | |
| 79.607% | |
| 57.0556% | |
| 66.6003% | |
| 64.6294% | |
| 53.0995% | |
| 49.3737% | |
| 22.6857% | |
| 5.6459% | |
| -23.1539% | |
| -41.4658% | |
| -11.487% | |
| -10.1296% | |
| 4.9504% | |
| 20.3232% | |
| 5.3277% | |
| 13.2172% | |
| 0.9185% | |
| -27.8349% | |
| -36.6554% | |
| -66.3292% | |
| -100.1985% | |
| -55.641% | |
| -96.7922% | |
| -452.9477% | |
| -487.2368% | |
| -5,348.0106% | |
| -2,864.1125% | |
| 38.7203% | |
| 76.2942% | |
| 103.8033% | |
| 42.7277% | |
| -22.9437% | |
| -106.0893% | |
| -180.7315% | |
| -273.997% |